Skip to main content
Premium Trial:

Request an Annual Quote

Protea Licenses Mass Spec Technology from GWU

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protea Biosciences today announced a worldwide licensing agreement with George Washington University for mass spectrometry-based technology.

The technology, called Laser Ablation Electrospray Ionization, or LAESI, can directly identify proteins, peptides, lipids, and metabolites in biological samples, including tissue, blood, urine, and single cells, Protea said in a statement.

Developed in the laboratory of Akos Vertes, a professor of chemistry, biochemistry and molecular biology at GWU and founder and co-director of the W.M. Keck Institute for Proteomics Technology, LAESI allows an analysis to be done in less than two seconds and enables 3-dimension mapping of biomolecules through depth profiling and lateral imaging, the Morgantown, W. Va.-based company added.

Little or no sample preparation is required, Protea said.

The technology is described in a study published yesterday in PLoS One, in which Vertes and his colleagues identified virally infected human cells.

Protea and the Vertes lab will now develop instrumentation and software for the technology, it said. Terms of the agreement were not disclosed.

"We foresee a broad range of commercial applications in chemical and biological research, surgical pathology, clinical diagnostics, chemical and biological defense, forensics, agriculture, and many other fields," Steve Turner, CEO of Protea, said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.